Endothelial dysfunction, increased carotid artery intima-media thickness and pulse wave velocity, and increased level of inflammatory markers are associated with variant angina

Journal of Cardiology

Volumn 54, Issue 2, 2009, Pages 183-191

  Cho, Sook Hee ^a   Jeong, Myung Ho ^a,b   Park, In Hyae ^c   Choi, Jin Soo ^b   Yoon, Hyun Ju ^a,b   Kim, Kye Hun ^a,b   Hong, Young Joon ^a,b   Park, Hyung Wook ^a,b   Kim, Ju Han ^a,b   Ahn, Youngkeun ^a,b   Cho, Jeong Gwan ^a,b   Park, Jong Chun ^a,b   Kang, Jung Chaee ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

Angina; Endothelium; Inflammation

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PULSE WAVE; THORAX PAIN; VARIANT ANGINA PECTORIS; VASODILATATION;

ANGINA PECTORIS, VARIANT; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CAROTID ARTERIES; CORONARY ANGIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HOMOCYSTEINE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PULSE; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 70349232361     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.05.003     Document Type: Article

References (35)

1. Kang J.A., Lee Y.S., Jeong S.H., Lee J.W., and Kim B.Y. Clinical characteristics of patients with variant angina. Kor J Intern Med 63 (2002) 195-202
2. Beltrame J.F., Sasayama S., and Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33 (1999) 1442-1452
3. Bertrand M.E., LaBlanche J.M., Tilmant P.Y., Thieuleux F.A., Delforge M.R., Carre A.G., Berzin B., Libersa C., and Laurent J.M. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary angiography. Circulation 65 (1982) 1299-1306
4. Pristipino C., Beltrame J.F., Finocchiaro M.L., Hattori R., Fujita M., Mongiardo R., Cianflone D., Sanna T., Sasayama S., and Maseri A. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101 (2000) 1102-1108
5. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 (1997) 1436-1442
6. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
7. MacAlpin R.N. Relation of coronary arterial spasm to sites of organic stenosis. Am J Cardiol 46 (1980) 143-153
8. Miyao Y., Kugiyama K., Kawano H., Motoyama T., Ogawa H., Yoshimura M., Sakamoto T., and Yasue H. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 36 (2000) 432-437
9. Suzuki H., Kawai S., Aizawa T., Kato K., Sunayama S., Okada R., and Yamaguchi H. Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. J Am Coll Cardiol 33 (1999) 198-205
10. Kugiyama K., Ohgushi M., Motoyama T., Sugiyama S., Ogawa H., Yoshimura M., Inobe Y., Hirashima O., Kawano H., Soejima H., and Yasue H. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 30 (1997) 920-926
11. -786 → C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
12. Synn Y.C., Bae J.H., and Kim K.Y. Correlation between endothelial function and the extent of coronary atherosclerosis. Kor Circ J 34 (2004) 752-760
13. Selwyn A.P., Kinlay S., Creager M., Libby P., and Ganz P. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. Am J Cardiol 79 (1997) 17-23
14. Grundy S.M., Pasternak R., Greenland P., Smith Jr. S., and Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100 (1999) 1481-1492
15. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creaqer M.A., Deanfield J., Drexler H., Gerhard-Herman M., Vallance P., Vita J., and Vogel R. International brachial artery reactivity task force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 39 (2002) 257-265
16. Amar J., Ruidavets J.B., Chamontin B., Drouet L., and Ferrieres J. Arterial stiffness and cardiovascular risk factors in population-based study. J Hypertens 19 (2001) 381-437
17. Tomiyama H., Yamashina A., Arai T., Hirose K., Koji Y., Chikamori T., Hori S., Yamamoto Y., Doba N., and Hinohara S. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects. Atherosclerosis 166 (2003) 303-309
18. Yufu K., Takahashi N., Anan F., Hara M., Yoshimatsu H., and Saikawa T. Brachial arterial stiffness predicts coronary atherosclerosis in patients at risk for cardiovascular diseases. Jpn Heart J 45 (2004) 231-242
19. van Popele N.M., Grobbee D.E., Bots M.L., Asmar R., Topouchian J., Reneman R.S., Hoeks A.P., van der Kuip D.A., Hofman A., and Witteman J.C. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 32 (2001) 454-460
20. Hung M.J., Kuo L.T., Cheng C.W., Chang C.P., and Cherng W.J. Comparison of peripheral monocyte counts in patients with and without coronary spasm and without fixed coronary narrowing. Am J Cardiol 93 (2004) 620-624
21. Hung M.J., Cherng W.J., Yang N.I., Cheng C.W., and Li L.F. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 96 (2005) 1484-1490
22. Hung M.J., Cherng W.J., Cheng C.W., and Li L.F. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. Am J Cardiol 97 (2006) 1429-1434
23. Cho S.H., Park I.H., Jeong M.H., Hwang S.H., Yun N.S., Hong S.N., Lee S.R., Kim J.H., Moon J.Y., Hong Y.J., Park H.Y., Kim J.H., Ahn Y.K., Cho J.G., Park J.C., et al. Increased inflammatory markers and endothelial function are associated with variant angina. Kor Circ J 37 (2007) 27-32
24. Ogawa H., Sakamoto T., Nishiyama K., Soejima H., Kaikita K., Takazoe K., Miyamoto S., Kugiyama K., Yoshimura M., and Yasue H. Elevated levels of soluble intercellular adhesion molecule-1 in the coronary circulation of patients with coronary organic stenosis and spasm. Jpn Circ J 64 (2000) 170-176
25. Umemoto S., Suzuki N., Fujii K., Fujii A., Fujii T., Iwami T., Ogawa H., and Matsuzaki M. Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris. Am J Cardiol 85 (2000) 715-719
26. Li J.J., Zhang Y.P., Yang P., Zeng H.S., Qian X.W., Zhang C.Y., Zhu C.G., Li J., and Nan J.L. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina. Coronary Artery Dis 19 (2008) 293-297
27. Fukuda D., Shimada K., Tanaka A., Kawarabayashi T., Yoshiyama M., and Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 43 (2004) 18-23
28. Kim N.H., Jeong J.W., Park E.M., Yun K.H., Yoo N.J., Lee E.M., Oh S.K., and Park O.K. Alterations of autonomic norvous activity associated with spontaneous coronary spasm in patients with variant angina. Kor Circ J 34 (2004) 362-367
29. Vita J.A., and Keaney Jr. J.F. Exercise-toning up the endothelium?. N Engl J Med 342 (2000) 503-505
30. Strandberg T.E., Vanhanen H., and Tikkanen M.J. Effect of statins on C-reactive protein in patients with coronary artery disease. Lancet 353 (1999) 118-119
31. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., Flaker G.C., and Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 98 (1998) 839-844
32. Dupuis J., Tardif J.C., Cernacek P., and Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 99 (1999) 3227-3233
33. Takayama T., Wada A., Tsutamoto T., Ohnishi M., Fujii M., Isono T., and Horie M. Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor. Circ J 68 (2004) 1067-1075
34. Lacoste L., Lam J.Y., and Hung J. Hyperlipidemia and coronary disease: correction of the increased thrombogenic potential with cholesterol reduction. Circulation 92 (1995) 3172-3177
35. Yamagishi M., Ito K., Tsutsui H., Miyazaki S., Goto Y., Nagaya N., Sumiyoshi T., Fukami K., Haze K., Kitakaze M., Nonogi H., and Tomoike H. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists. Circ J 67 (2003) 1029-1035